BIOLOGICAL-ACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF REQUIRES MEMBRANE TARGETING BY C-TERMINAL BASIC DOMAINS

被引:66
|
作者
GONCALVES, J
SHI, B
YANG, XY
GABUZDA, D
机构
[1] DANA FARBER CANC INST,DIV HUMAN RETROVIROL,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115
[3] HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115
关键词
D O I
10.1128/JVI.69.11.7196-7204.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type 1 (HIV-1) encodes a Vif protein which is important for virus replication and infectivity. Vif is a cytoplasmic protein which exists in both membrane-associated and soluble forms. The membrane-associated form is an extrinsic membrane protein which is tightly associated with the cytoplasmic side of membranes. We have analyzed the mechanism of membrane targeting of Vif and its role in HIV-1 replication, Mutagenesis studies demonstrate that C-terminal basic domains are required for membrane association. Vif mutations which disrupt membrane association also inhibit HIV-1 replication, indicating that membrane localization of Vif is likely to be required for its biological activity in vivo. Membrane binding of Vif is almost completely abolished by trypsin treatment of membranes, These results demonstrate that membrane localization of Vif requires C-terminal basic domains and interaction with a membrane-associated protein(s), This interaction may serve to direct Vif to a specific cellular site, since immunofluorescence staining and plasma membrane fractionation studies show that Vif is localized predominantly to an internal cytoplasmic compartment rather than to the plasma membrane, The mechanism of membrane targeting of Vif is different in some respects from that of other extrinsic membrane proteins, such as Ras, Src, and MARCKS, which utilize a basic domain together with a lipid modification for membrane targeting. Membrane targeting of Vif is likely to play an important role in HIV-1 replication and thus may be a therapeutic target.
引用
收藏
页码:7196 / 7204
页数:9
相关论文
共 50 条
  • [41] INVIVO ACTIVATION BY ULTRAVIOLET RAYS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT
    CAVARD, C
    ZIDER, A
    VERNET, M
    BENNOUN, M
    SARAGOSTI, S
    GRIMBER, G
    BRIAND, P
    JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (04): : 1369 - 1374
  • [42] TRANSCELLULAR ACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT IN COCULTURED LYMPHOCYTES
    MARCUZZI, A
    WEINBERGER, J
    WEINBERGER, OK
    JOURNAL OF VIROLOGY, 1992, 66 (07) : 4228 - 4232
  • [43] THE LONG TERMINAL REPEAT IS NOT A MAJOR DETERMINANT OF THE CELLULAR TROPISM OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    POMERANTZ, RJ
    FEINBERG, MB
    ANDINO, R
    BALTIMORE, D
    JOURNAL OF VIROLOGY, 1991, 65 (02) : 1041 - 1045
  • [44] MOLECULAR-BIOLOGY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    HASELTINE, WA
    FASEB JOURNAL, 1991, 5 (10): : 2349 - 2360
  • [45] STIMULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 EXPRESSION BY CERAMIDE
    PAPP, B
    ZHANG, DZ
    GROOPMAN, JE
    BYRN, RA
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (07) : 775 - 780
  • [46] VIRAL DYNAMICS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    WEI, XP
    GHOSH, SK
    TAYLOR, ME
    JOHNSON, VA
    EMINI, EA
    DEUTSCH, P
    LIFSON, JD
    BONHOEFFER, S
    NOWAK, MA
    HAHN, BH
    SAAG, MS
    SHAW, GM
    NATURE, 1995, 373 (6510) : 117 - 122
  • [47] INFECTIOUS DECAY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN PLASMA
    MOUDGIL, T
    DAAR, ES
    JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01): : 210 - 212
  • [48] VIRAL DYNAMICS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    SHAW, GM
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 : S83 - S83
  • [49] QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION KINETICS
    DIMITROV, DS
    WILLEY, RL
    SATO, H
    CHANG, LJ
    BLUMENTHAL, R
    MARTIN, MA
    JOURNAL OF VIROLOGY, 1993, 67 (04) : 2182 - 2190
  • [50] MOLECULAR INSIGHTS INTO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PATHOGENESIS
    FEINBERG, MB
    GREENE, WC
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (04) : 466 - 474